{"action":"elsewhere","city":"WILMINGTON","companyRegistrationNumber":null,"conformityFlag":"CONFORMING","country":"US","createdAt":"2007-06-21T00:00:00.000Z","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[],"parents":[{"active":true,"country":"CH","legalName":"Glenmark Holding SA","lei":"506700E62GR12JRI9878","relationshipTypes":["IS_DIRECTLY_CONSOLIDATED_BY"]},{"active":true,"country":"IN","legalName":"GLENMARK PHARMACEUTICALS LIMITED","lei":"335800WKECZXIIT9GK20","relationshipTypes":["IS_ULTIMATELY_CONSOLIDATED_BY"]}]},"headquartersAddress":"251 LITTLE FALLS DRIVE","headquartersCity":"WILMINGTON","headquartersCountry":"US","headquartersPostalCode":"19808","headquartersRegion":"US-DE","lastUpdatedAt":"2026-03-11T15:23:35.131Z","legalAddress":"C/O CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE","legalFormAbbreviation":null,"legalFormCode":"XTIQ","legalFormName":"Corporation","legalJurisdiction":"US-DE","legalName":"GLENMARK THERAPEUTICS INC., USA","lei":"254900JFDC6JEPHQF612","managingLou":"5493001KJTIIGC8Y1R12","managingLouName":"Bloomberg","managingLouWebsite":"http://lei.bloomberg.com","nextRenewalAt":"2027-03-11T15:23:35.131Z","otherLegalForm":null,"postalCode":"19808","region":"US-DE","registeredAt":"2026-03-11T15:23:35.131Z","registrationAuthorityId":"RA000602","registrationAuthorityName":"Division of Corporations, Department of State","registrationAuthorityWebsite":"https://corp.delaware.gov/","registrationNumber":"4375841","registrationNumberFormatted":"4375841","registrationStatus":"ISSUED","served":false,"successorLeis":[],"validationAuthorityEntityId":"4375841","validationAuthorityId":"RA000602","validationAuthorityName":"Division of Corporations, Department of State","validationSources":"FULLY_CORROBORATED"}